Biotech: Pressemitteilungen - Kategorie - Seite 247

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Bio Solutions Corp./Type2 Defense: Product Update

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 09/06/11 -- (OTCBB: BISU)(PINK SHEETS: BISU) - Bio Tech marketing company Bio Solutions Corp. is pleased to provide a Type2 Defense product update. "With our ...

Threshold Pharmaceuticals to Present at Rodman & Renshaw 13th Annual Healthcare Conference

REDWOOD CITY, CA: REDWOOD CITY, CA -- (Marketwire) -- 09/06/11 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to presen ...

Proteonomix (PROT) Senior Management Meets With Investment Community

MOUNTAINSIDE, NJ: MOUNTAINSIDE, NJ -- (Marketwire) -- 09/06/11 -- PROTEONOMIX, INC. (OTCBB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, a ...

Critical Outcome Technologies Inc. Selected for Consulate General of Canada Life Sciences Partnering Mission

LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 09/06/11 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that the Company was selected by the Consulate General of Canada and BIOTE ...

Cleveland BioLabs to Present at Rodman & Renshaw 13th Annual Healthcare Conference

BUFFALO, NY: BUFFALO, NY -- (Marketwire) -- 09/06/11 -- (NASDAQ: CBLI) today announced that the Company is scheduled to present at the Rodman & Renshaw 13th Annual Healthcare Conference, September 11-13, in N ...

Poniard Pharmaceuticals Receives Favorable NASDAQ Decision for Continued Listing of Company Shares

SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwire) -- 09/06/11 -- Poniard Pharmaceuticals, Inc. (NASDAQ: PARD), a biopharmaceutical company focused on the development and commercialization of innovative oncology prod ...

Theratechnologies Launches Phase 2 Clinical Trial to Investigate Tesamorelin for the Treatment of COPD-Associated Muscle Wasting

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 09/06/11 -- Theratechnologies Inc. (TSX: TH)(NASDAQ: THER) announced today that it has initiated the patient screening process of its phase 2 clinical trial inves ...

Late-Stage Products From BioSante and Keryx Gaining Momentum

NEW YORK, NY: The Bedford Report Provides Equity Research on BioSante & Keryx Biopharmaceuticals ...

AEterna Zentaris and AVI BioPharma Maintain Steady Pipelines

NEW YORK, NY: The Bedford Report Provides Equity Research on AEterna Zentaris & AVI BioPharma ...

Paladin Labs Inc. Issues Update Regarding Jonathan Ross Goodman

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 09/06/11 -- Paladin Labs Inc. ("Paladin" or the "Company") (TSX: PLB), a leading Canadian specialty pharmaceutical company, today provided an ...

Aposense Cancer Drug Demonstrates 100% Oral Bioavailability in New Study

PETACH-TIKVA, ISRAEL: Animal Study of Anticancer Agent ATT-11T -- a New Irinotecan Analogue -- Could Lead to Clinical Trials ...

ProMetic BioSciences Ltd Provides Corporate Update

ISLE OF MAN, UNITED KINGDOM: - $0.8 million working capital grant from the Isle of Man Government received to support revenue growth - Revenues from PBL operations expected to exceed $6.0 million in H2 2011 - 5th consecutive yea ...

Warnex Launches New Website: www.pca3.ca

LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 09/06/11 -- Warnex Inc. (TSX: WNX) announced today the launch of its new website for its PCA3 test for prostate cancer detection, available throughout Canada. Warne ...

Completion of Privatization of Ondine

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/06/11 -- Ondine Biomedical Inc. (the "Company" or "Ondine") (TSX: OBP)(AIM: OBP) announced the completion today of the previousl ...

Pacgen Announces Private Placement Financing

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/02/11 -- Pacgen Biopharmaceuticals Corporation (the "Company" or "Pacgen") (TSX VENTURE: PGA) announced today that it has reache ...

Threshold Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference

REDWOOD CITY, CA: REDWOOD CITY, CA -- (Marketwire) -- 09/02/11 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present ...

Medicopia Life Sciences: A Powerful, New Approach to Pain Therapy

MONTREAL, QUEBEC: Health Canada approves new line of safe, effective, 100% natural, Canadian-made medications from Medicopia(TM) ...

Vet-Stem CEO Invited to Give Keynote Presentation at the 7th World Congress of Veterinary Dermatology in Vancouver, BC

POWAY, CA: POWAY, CA -- (Marketwire) -- 09/01/11 -- Vet-Stem, Inc. announced that Dr. Robert Harman, DVM, MPVM, CEO of Vet-Stem, will present a keynote presentation titled "Stem Cell Therapy in Veterinary ...

Ondine Receives Final Court Order for Privatization

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/01/11 -- Ondine Biomedical Inc. (the "Company" or "Ondine", (TSX: OBP)(AIM: OBP) announced that it has today obtained a final or ...

Aeolus Pharmaceuticals' Announces Presentation of AEOL10150 Data at the 14th International Congress of Radiation Research

MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 09/01/11 -- Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company that is leveraging up to $140M of government funding in develo ...


Seite 247 von 255:  « ..  246 247 248  249  250  251  252  253  254  255 





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z